Prostate Cancer Current Events | Prostate Cancer News | 5
|
| Page
5 of
99 |
1971 Results |
|
|
|
Sort By:
Page Views | Date |
SPCG-4 trial: Update on watchful waiting versus radical prostatectomy
In 2005, the Scandinavian Prostate Cancer Group Study 4 (SPCG-4) reported that radical prostatectomy improved prostate cancer survival compared with watchful waiting after a median of 8.2 years of follow-up. view more (2009-03-23)
Researchers uncover how prostate cancer cells defy death
New findings about how prostate cancer cells are able to resist hormone treatment and defy death may lead to more effective drug treatments. view more (2006-07-31)
Common painkillers lower levels of prostate cancer biomarker
Common painkillers like aspirin and ibuprofen appear to lower a man's PSA level, the blood biomarker widely used by physicians to help gauge whether a man is at risk of prostate cancer. view more (2008-09-09)
New lab evidence suggests preventive effect of herbal supplement in prostate cancer
DHEA is a natural circulating hormone and the body's production of it decreases with age. Men take DHEA as an over-the-counter supplement because it has been suggested that DHEA can reverse aging or have anabolic effects since it can be metabolized in the body to androgens. view more (2009-02-12)
TARGETED BONE THERAPY COULD IMPROVE SURVIVAL OUTCOME FOR PATIENTS WITH ADVANCED PROSTATE CANCER (pp 326, 336)
Patients responding to chemotherapy for advanced prostate cancer could have increased survival times if specific therapy is targeted at sites of skeletal metastases, concludes research published in this week’s issue of THE LANCET. Prostate cancer tends to spread to the bones, and there is a direct relation between the extent of bone... view more... (2001-01-31)
Shrinkage of prostate led to overestimation of cancer risk in trial
Reanalysis of data from the first long-term randomized trial of a chemopreventive agent for prostate cancer shows that the excess prevalence of high-grade prostate cancer in the drug-treated group may be attributable to shrinkage of the prostate at the time of biopsy. view more (2007-09-13)
Study first: Over-expression of Cox-2 can predict prostate cancer outcome
Researchers say an over-expression of COX-2 in men with prostate cancer is associated with an increase in PSA after radiation treatment and the spread of the cancer outside of the prostate. view more (2006-11-09)
Prostate cancer gene test provides new early detection
Prostate cancer (PCa) is one of the most common male cancers in the Western world. Currently, early detection of PCa depends on an abnormal digital rectal examination and an elevated prostate-specific-antigen (PSA) level requiring a prostate biopsy, often associated with anxiety, discomfort, complications, and heavy expenses. view more (2008-10-17)
Lowering your cholesterol may decrease your risk of cancer
Current research suggests that lowering cholesterol may block the growth of prostate tumors. The related report by Solomon et al, "Ezetimibe Is an Inhibitor of Tumor Angiogenesis," appears in the March 2009 issue of The American Journal of Pathology. view more (2009-02-24)
Rapidly rising PSA before treatment is key indicator of cancer spread
Results of a new Fox Chase Cancer Center study show that men with a rapidly rising PSA level before treatment have a high probability of metastatic disease and should receive hormone therapy in addition to radiation. view more (2006-11-09)
VA researcher finds way to identify which men need a second biopsy
A researcher in the Oregon Health & Science University Cancer Institute and Portland Veterans Affairs Medical Center has found a way to identify which men need a second prostate biopsy because they may be harboring life-threatening prostate cancer even though they were given a clean bill of health after their first biopsy. view more (2007-02-23)
Survival predictors may help customize treatment options for men with metastatic prostate cancer
Four risk factors that help predict how long men may survive with metastatic prostate cancer could help doctors choose more effective treatments, according to a study led by researchers in the Duke Comprehensive Cancer Center. view more (2009-05-15)
Genes may play role in risk assessment for prostate cancer among Hispanics and caucasians
Genetic differences may explain the greater risk for prostate cancer among Caucasian men compared with Hispanic men, which could help clinicians predict who is more likely to develop the disease. view more (2008-05-15)
Results of phase I trial of novel herbal therapy for men at high risk of prostate cancer
Results of a phase I clinical trial of a novel herb-based therapeutic called Zyflamend have demonstrated that the therapy is associated with minimal toxicity and no serious adverse events in men at high-risk for developing prostate cancer. view more (2009-05-26)
Cellular molecule spurs growth of prostate cancer
University of North Carolina at Chapel Hill scientists have identified a molecule that stimulates the aggressive growth of prostate cancer. view more (2005-11-29)
Androgen deprivation therapy does not keep localized prostate cancer from spreading, new study says
Oregon Health & Science University Cancer Institute researchers wanted to know if depriving men of testosterone actually keeps cancer from spreading beyond the prostate. view more (2006-02-27)
New finding suggests prostate biopsy is not always necessary
Researchers at Wake Forest University School of Medicine and the University of Wisconsin-Madison have discovered that some elevated prostate-specific antigen (PSA) levels in men may be caused by a hormone normally occurring in the body, and are not necessarily a predictor of the need for a prostate biopsy. view more (2009-11-09)
Why prostate cancer patients fail hormone deprivation therapy
The hormone deprivation therapy that prostate cancer patients often take gives them only a temporary fix, with tumors usually regaining their hold within a couple of years. view more (2009-01-05)
Study finds acceptable levels of anxiety among men living with early, untreated prostate cancer
Men with early stages of prostate cancer who delay radical treatment in favor of an approach of "expectant management" do not have high levels of anxiety and distress. view more (2009-07-27)
OHSU Cancer Institute, VA researchers find way to identify which men need a second biopsy
A researcher in the Oregon Health & Science University Cancer Institute and Portland Veterans Affairs Medical Center has found a way to identify which men need a second prostate biopsy because they may be harboring life-threatening prostate cancer even though they were given a clean bill of health after their first biopsy. view more (2007-06-04)
|
|
| Page
5 of
99 |
1971 Results |
|
|
|
Sort By:
Page Views | Date |
|
